Cargando…
Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
Autores principales: | Mehta, Puja, Chambers, Rachel C, Dagna, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969129/ https://www.ncbi.nlm.nih.gov/pubmed/33754142 http://dx.doi.org/10.1016/S2665-9913(21)00078-3 |
Ejemplares similares
-
Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021) -
IL-33 in COVID-19: friend or foe?
por: Liang, Yuejin, et al.
Publicado: (2021) -
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
por: Mehta, Puja, et al.
Publicado: (2020) -
Social media: friend or foe in the COVID-19 pandemic?
por: Lima, Diego Laurentino, et al.
Publicado: (2020) -
Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era
por: Alkan, Ali, et al.
Publicado: (2020)